etomoxir has been researched along with Alloxan Diabetes in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 6 (46.15) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clarke, K; Gibbons, GF; Hauton, D; Murray, AJ; Panagia, M | 1 |
| Abdel-aleem, S; Anstadt, MP; Badr, M; Lowe, JE; Sayed-Ahmed, M; Sharwi, S | 1 |
| Dhalla, NS; Elimban, V; Rupp, H | 1 |
| Collier, GR; Macaulay, SL; O'Dea, K; Traianedes, K | 1 |
| Reinauer, H; Rösen, P; Schmitz, FJ | 1 |
| Chapman, DC; Dhalla, NS; Kato, K; Lukas, A; Rupp, H | 1 |
| Bristow, M | 1 |
| Hayakawa, T; Hayashi, K; Kamiya, H; Matsui, H; Murase, K; Numaguchi, Y; Okumura, K; Saburi, Y; Toki, Y | 1 |
| Bitar, MS | 1 |
| Adrian, M; Reinauer, H; Rösen, P; Schmitz, FJ | 1 |
| Lopaschuk, GD; Spafford, M | 1 |
| Lopaschuk, GD; Wall, SR | 1 |
| Chang, H; Hoffman, BB; Reaven, GM | 1 |
13 other study(ies) available for etomoxir and Alloxan Diabetes
| Article | Year |
|---|---|
Plasma free fatty acids and peroxisome proliferator-activated receptor alpha in the control of myocardial uncoupling protein levels.
Topics: Animals; Body Weight; Carrier Proteins; Diabetes Mellitus, Experimental; Epoxy Compounds; Fatty Acids, Nonesterified; Homeostasis; Hypoglycemic Agents; Insulin; Ion Channels; Membrane Proteins; Membrane Transport Proteins; Mice; Mice, Knockout; Mitochondrial Proteins; Peroxisome Proliferators; PPAR alpha; Pyrimidines; Triglycerides; Uncoupling Protein 1; Uncoupling Protein 2; Uncoupling Protein 3 | 2005 |
Reduced induction of carbohydrate utilization by inhibition of fatty acid oxidation in myocytes from diabetic animals.
Topics: Animals; Carbohydrate Metabolism; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Epoxy Compounds; Fatty Acids; Glucose; Hypoglycemic Agents; Male; Myocardium; Oxidation-Reduction; Palmitates; Pyruvate Dehydrogenase Complex; Pyruvates; Pyruvic Acid; Rats; Rats, Sprague-Dawley | 1995 |
Modification of myosin isozymes and SR Ca(2+)-pump ATPase of the diabetic rat heart by lipid-lowering interventions.
Topics: Animals; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Calcium-Transporting ATPases; Cyclopropanes; Diabetes Mellitus, Experimental; Epoxy Compounds; Heart; Heart Rate; Hypolipidemic Agents; Imidazoles; Male; Myosins; Propranolol; Pyrazines; Rats; Rats, Sprague-Dawley; Sarcoplasmic Reticulum | 1994 |
Effect of fatty acid oxidation inhibition on glucose metabolism in diabetic rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Epoxy Compounds; Fasting; Fatty Acids; Fatty Acids, Nonesterified; Glucose; Insulin; Liver; Male; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Triglycerides | 1993 |
Improvement of myocardial function and metabolism in diabetic rats by the carnitine palmitoyl transferase inhibitor Etomoxir.
Topics: Animals; Carnitine; Carnitine O-Palmitoyltransferase; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Epoxy Compounds; Glucose; Heart; Hypoglycemic Agents; Lipid Metabolism; Male; Rats; Rats, Wistar; Streptozocin | 1995 |
Alterations of heart function and Na+-K+-ATPase activity by etomoxir in diabetic rats.
Topics: Animals; Blood Pressure; Blotting, Western; Ca(2+) Mg(2+)-ATPase; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Epoxy Compounds; Heart; Heart Rate; Hemodynamics; Hypoglycemic Agents; Isoenzymes; Lipids; Male; Myocardium; Ouabain; Rats; Rats, Sprague-Dawley; Sarcolemma; Sodium-Potassium-Exchanging ATPase | 1999 |
Etomoxir: a new approach to treatment of chronic heart failure.
Topics: Animals; Carnitine O-Palmitoyltransferase; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Epoxy Compounds; Heart Failure; Humans; Hypoglycemic Agents; Rats | 2000 |
Involvement of 1,2-diacylglycerol in improvement of heart function by etomoxir in diabetic rats.
Topics: Animals; Blood Pressure; Carnitine; Ceramides; Diabetes Mellitus, Experimental; Diglycerides; Echocardiography; Enzyme Inhibitors; Epoxy Compounds; Fatty Acids; Heart Rate; Hypoglycemic Agents; Male; Myocardium; Rats; Rats, Wistar; Streptozocin; Ventricular Dysfunction, Left | 2001 |
Co-administration of etomoxir and RU-486 mitigates insulin resistance in hepatic and muscular tissues of STZ-induced diabetic rats.
Topics: Animals; Carnitine O-Palmitoyltransferase; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Enzyme Inhibitors; Epoxy Compounds; Fatty Acids, Nonesterified; Glucose; Hormone Antagonists; Insulin Resistance; Liver; Male; Mifepristone; Mitochondria; Muscle, Skeletal; Rats; Rats, Wistar | 2001 |
Influence of carnitine acyltransferase inhibitors on the performance and metabolism of rat cardiac muscle.
Topics: Acyltransferases; Animals; Carnitine; Carnitine O-Palmitoyltransferase; Chemical Phenomena; Chemistry; Diabetes Mellitus, Experimental; Epoxy Compounds; Ethers, Cyclic; Glucose; Heart; In Vitro Techniques; Liver; Male; Myocardium; Rats; Rats, Inbred Strains; Rats, Zucker; Triglycerides | 1990 |
Response of isolated working hearts to fatty acids and carnitine palmitoyltransferase I inhibition during reduction of coronary flow in acutely and chronically diabetic rats.
Topics: Acute Disease; Acyl Coenzyme A; Acyltransferases; Animals; Carnitine O-Palmitoyltransferase; Chronic Disease; Coronary Disease; Diabetes Mellitus, Experimental; Epoxy Compounds; Fatty Acids; Heart; In Vitro Techniques; Male; Myocardium; Phosphocreatine; Rats; Rats, Inbred Strains; Streptozocin; Thiourea | 1989 |
Glucose oxidation rates in fatty acid-perfused isolated working hearts from diabetic rats.
Topics: Adenosine Triphosphate; Animals; Carnitine O-Palmitoyltransferase; Diabetes Mellitus, Experimental; Epoxy Compounds; Fatty Acids; Glucose; Heart; In Vitro Techniques; Male; Myocardium; Oxidation-Reduction; Palmitates; Rats; Rats, Inbred Strains | 1989 |
Additive hypoglycemic effects of drugs that modify free-fatty acid metabolism by different mechanisms in rats with streptozocin-induced diabetes.
Topics: Adipose Tissue; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Drug Interactions; Drug Therapy, Combination; Epoxy Compounds; Ethers, Cyclic; Fatty Acids, Nonesterified; Hypoglycemic Agents; Insulin; Lipolysis; Male; Niacin; Rats; Rats, Inbred Strains; Triglycerides | 1988 |